Sandoz launches its first RFID-tagged critical injectable medicines with Kit Check to optimize supply chain and automate restocking in US hospitals
The first two medicines include Anectine 200 mg/10mL and Rocuronium 50mg/5mL and 10mg/5mL (paralytics to relax muscles during surgery or other medical procedures). Several more Sandoz medicines are expected to be made available to Kit Check's hospital partners through early 2021.
Through its collaboration with Kit Check, Sandoz will help hospital pharmacies improve efficiency, reduce risk and better support patient treatment in hospitals by providing real-time inventory reports and timely tracking of expiration of products and recalls. This will aid in automatic replenishment of supplies long-term.
Especially during a pandemic, ensuring medicines are readily available, in addition to keeping prices stable, is paramount to patient care when healthcare systems are already being challenged and overwhelmed. Both Sandoz and Kit Check are members of the newly formed industry consortium DoseID, launched in August 2020 to ensure standardization and interoperability of RFID in the pharmaceutical supply chain.
Kit Check is a leader in RFID-based medication inventory tracking and automated tray processing in use at more than 500 hospitals in the US and Canada. RFID tags are applied to vials, syringes, bags, and other medication packages and supplies in trays and kits and used to track each medication that passes through the hospital pharmacies. Scanners will automatically identify the products in terms of NDC, lot number, and expiration date, saving time for hospital staff and reducing the risk of medical error. As a result, the pharmacy can see the product's journey from the plant to the point of administration in real time.
No comments: